Complete financial analysis of M3, Inc. (2413.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of M3, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Nissan Securities Group Co., Ltd. (8705.T) Income Statement Analysis – Financial Results
- Nordic LEVEL Group AB (publ.) (LEVEL.ST) Income Statement Analysis – Financial Results
- Pacific Ventures Group, Inc. (PACV) Income Statement Analysis – Financial Results
- Parrot SA (PABSA.PA) Income Statement Analysis – Financial Results
- Lex Computech Co., Ltd. (7562.TWO) Income Statement Analysis – Financial Results
M3, Inc. (2413.T)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://corporate.m3.com
About M3, Inc.
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 238.88B | 230.82B | 208.16B | 169.20B | 130.97B | 113.06B | 94.47B | 78.14B | 64.66B | 51.35B | 36.89B | 26.01B | 19.04B | 14.65B | 11.81B | 8.53B | 7.48B | 5.73B | 3.85B | 2.28B |
| Cost of Revenue | 105.71B | 95.63B | 84.89B | 65.80B | 58.09B | 49.22B | 40.72B | 32.10B | 26.97B | 20.50B | 11.90B | 7.61B | 4.78B | 3.83B | 3.31B | 1.87B | 1.69B | 1.42B | 970.07M | 567.00M |
| Gross Profit | 133.18B | 135.19B | 123.27B | 103.40B | 72.89B | 63.84B | 53.75B | 46.04B | 37.69B | 30.85B | 24.99B | 18.40B | 14.26B | 10.82B | 8.50B | 6.67B | 5.78B | 4.31B | 2.88B | 1.71B |
| Gross Profit Ratio | 55.75% | 58.57% | 59.22% | 61.11% | 55.65% | 56.47% | 56.89% | 58.92% | 58.29% | 60.08% | 67.74% | 70.74% | 74.89% | 73.87% | 71.95% | 78.12% | 77.37% | 75.23% | 74.83% | 75.09% |
| Research & Development | 0.00 | 0.00 | 0.00 | 46.00M | 9.00M | 21.00M | 41.00M | 49.00M | 14.00M | 25.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 59.59B | 64.83B | 56.07B | 45.04B | 38.70B | 36.05B | 27.05B | 22.27B | 18.38B | 15.60B | 551.21M | 303.39M | 665.21M | 321.54M | 256.82M | 201.82M | 257.63M | 0.00 | 97.36M | 80.29M |
| Selling & Marketing | 8.05B | 8.54B | 7.05B | 5.98B | 4.72B | 3.67B | 3.29B | 3.26B | 3.11B | 2.98B | 2.94B | 2.49B | 1.10B | 1.57B | 854.68M | 683.92M | 511.00M | 387.03M | 250.13M | 124.68M |
| SG&A | 67.65B | 64.83B | 56.07B | 45.04B | 38.70B | 36.05B | 27.05B | 22.27B | 18.38B | 15.60B | 3.49B | 2.79B | 1.77B | 1.90B | 1.11B | 885.74M | 768.63M | 387.03M | 347.49M | 204.96M |
| Other Expenses | 0.00 | 0.00 | 979.00M | 362.00M | -259.00M | -2.91B | -2.99B | -1.05B | -639.00M | -778.00M | 111.70M | 59.43M | -13.90M | -7.33M | 3.78M | 11.24M | -4.70M | 16.82M | -1.15M | -19.46M |
| Operating Expenses | 67.65B | 64.68B | 57.05B | 45.40B | 38.44B | 33.15B | 24.07B | 21.22B | 17.74B | 14.82B | 12.66B | 9.10B | 3.95B | 3.34B | 2.26B | 1.72B | 1.40B | 869.89M | 710.92M | 472.64M |
| Cost & Expenses | 173.36B | 160.31B | 141.94B | 111.20B | 96.53B | 82.36B | 64.79B | 53.32B | 44.71B | 35.32B | 24.56B | 16.71B | 8.74B | 7.17B | 5.58B | 3.59B | 3.09B | 2.29B | 1.68B | 1.04B |
| Interest Income | 4.85B | 2.40B | 1.10B | 404.00M | 312.00M | 154.00M | 41.00M | 13.00M | 79.00M | 121.00M | 22.89M | 22.33M | 25.40M | 16.68M | 20.66M | 47.95M | 50.96M | 19.26M | 5.39M | 294.00K |
| Interest Expense | 391.00M | 69.00M | 52.00M | 111.00M | 39.00M | 12.00M | 54.00M | 104.00M | 150.00M | 8.00M | 30.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 8.88B | 7.43B | 6.27B | 5.74B | 4.49B | 1.39B | 1.16B | 939.00M | 867.00M | 671.00M | 865.26M | 612.88M | 556.67M | 374.96M | 277.64M | 144.78M | 136.35M | 124.81M | 69.22M | 61.89M |
| EBITDA | 78.11B | 77.85B | 73.64B | 64.08B | 39.14B | 29.19B | 28.20B | 24.82B | 20.47B | 16.85B | 14.31B | 10.12B | 8.29B | 8.40B | 5.40B | 5.09B | 4.52B | 3.56B | 2.27B | 1.30B |
| EBITDA Ratio | 32.70% | 35.45% | 44.71% | 37.89% | 29.89% | 28.59% | 32.72% | 33.27% | 32.42% | 32.82% | 33.36% | 38.22% | 70.64% | 63.26% | 64.48% | 70.69% | 73.17% | 75.01% | 70.92% | 72.03% |
| Operating Income | 65.53B | 71.98B | 95.14B | 57.97B | 34.34B | 30.80B | 29.71B | 25.05B | 20.02B | 16.06B | 12.32B | 9.29B | 10.30B | 7.48B | 6.24B | 4.94B | 4.39B | 3.44B | 2.17B | 1.24B |
| Operating Income Ratio | 27.43% | 31.19% | 45.71% | 34.26% | 26.22% | 27.24% | 31.45% | 32.06% | 30.97% | 31.28% | 33.41% | 35.74% | 54.12% | 51.06% | 52.79% | 57.91% | 58.68% | 60.05% | 56.39% | 54.33% |
| Total Other Income/Expenses | 3.31B | 2.34B | 1.05B | -98.00M | 273.00M | 142.00M | -14.00M | -91.00M | -72.00M | 113.00M | 189.00M | 210.25M | 84.37M | -1.99B | -2.13B | -898.29M | -942.91M | -671.30M | -507.66M | -364.73M |
| Income Before Tax | 68.84B | 74.32B | 96.19B | 58.26B | 34.61B | 30.94B | 29.70B | 24.96B | 19.95B | 16.17B | 13.64B | 9.50B | 7.73B | 6.04B | 5.13B | 4.04B | 3.44B | 2.77B | 1.69B | 872.13M |
| Income Before Tax Ratio | 28.82% | 32.20% | 46.21% | 34.44% | 26.43% | 27.37% | 31.44% | 31.94% | 30.85% | 31.50% | 36.98% | 36.54% | 40.61% | 41.21% | 43.40% | 47.39% | 46.06% | 48.33% | 43.95% | 38.31% |
| Income Tax Expense | 20.29B | 22.34B | 30.08B | 17.07B | 10.46B | 9.60B | 8.92B | 8.02B | 6.46B | 5.75B | 4.87B | 3.65B | 3.09B | 2.48B | 2.15B | 1.66B | 1.49B | 1.16B | 714.79M | 379.05M |
| Net Income | 45.27B | 49.03B | 63.85B | 37.82B | 21.64B | 19.58B | 19.68B | 16.00B | 12.51B | 9.76B | 8.32B | 5.60B | 4.49B | 3.49B | 2.96B | 2.36B | 1.97B | 1.61B | 991.67M | 493.08M |
| Net Income Ratio | 18.95% | 21.24% | 30.67% | 22.35% | 16.52% | 17.32% | 20.84% | 20.48% | 19.34% | 19.01% | 22.55% | 21.53% | 23.60% | 23.81% | 25.03% | 27.69% | 26.29% | 28.09% | 25.73% | 21.66% |
| EPS | 66.68 | 72.22 | 94.06 | 55.73 | 31.89 | 30.22 | 30.39 | 24.72 | 19.33 | 15.09 | 13.05 | 8.82 | 7.11 | 5.55 | 4.71 | 3.77 | 3.16 | 2.61 | 1.61 | 0.82 |
| EPS Diluted | 66.63 | 72.17 | 93.98 | 55.68 | 31.88 | 30.20 | 30.37 | 24.70 | 19.31 | 15.06 | 12.99 | 8.77 | 7.05 | 5.49 | 4.65 | 3.72 | 3.09 | 2.52 | 1.54 | 0.81 |
| Weighted Avg Shares Out | 678.93M | 678.89M | 678.77M | 678.66M | 678.45M | 647.81M | 647.61M | 647.40M | 647.15M | 646.66M | 637.34M | 635.02M | 632.05M | 628.71M | 628.05M | 626.82M | 621.62M | 617.42M | 616.32M | 597.76M |
| Weighted Avg Shares Out (Dil) | 679.46M | 679.33M | 679.35M | 679.32M | 678.70M | 648.15M | 648.04M | 647.97M | 647.90M | 647.83M | 640.17M | 638.40M | 637.17M | 635.64M | 635.19M | 635.00M | 635.12M | 637.31M | 642.16M | 607.20M |
Source: https://incomestatements.info
Category: Stock Reports